Definium Therapeutics logo

Definium Therapeutics

Brand · Biotechnology Research

Company overview

Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future.Definium Therapeutics trades on the NASDAQ under the symbol DFTX.
Founded in 2019
New York, New York, USA
103 employees
www.definiumtx.com

Salaries

Typical salary range

$216,329 – $245,300

/ yr

Help build salary transparency at Definium Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Founders and leadership

Robert Barrow
Robert Barrow
Chief Executive Officer
At the company for 5 years 3 months

Hiring contacts

Annette Polidora
Annette Polidora
Senior Talent Acquisition Advisor
At the company for 1 year 2 months
Jamie Schmid
Head of Human Resources
At the company for 1 year 3 months

Hiring activity

Open marketing jobs over time

7 open now

Headcount trend

Company growth over the last 12 months

Audience

LinkedIn followers

Follower count and growth

Total followers

41.3K

12-mo growth

—

Monthly growth

+8988.1%

Links

www.definiumtx.comLinkedIn